14. Mitteilungsblatt Nr. 14. Mitteilungsblatt der Medizinischen Universität Wien Studienjahr 2020/ Stück; Nr. 14. Bevollmächtigungen

(1)

14. Mitteilungsblatt Nr. 14

Mitteilungsblatt der Medizinischen Universität Wien Studienjahr 2020/2021

14. Stück; Nr. 14

Bevollmächtigungen

(2)

14. Bevollmächtigungen gem. § 27 Abs. 2 UG

Gemäß § 27 Abs. 2 UG werden folgende Bevollmächtigungen erteilt:

Auftragsnummer Projekttitel Projektleiter(in) Organisationseinheit APP31186FW Mechanisms of IL-2 induced

Transplantation Tolerance Pilat-Michalek Nina Allgemeinchirurgie_731 A Phase I/II, randomized,

prospective, controlled, multi- cneter, open-label, two arm study evaluating the safety and preliminary efficacy of sFilm-FS in controlling parenchymal bleeding during elective hepatic surgery

Kaczirek Klaus Allgemeinchirurgie_731

AP17078BGM Prospective Randomized Clinical Trial of Total Thyroidectomy (Tx) versus Thionamides (Anti- Thyroid Drugs) in Patients with Moderate-to-Severe Graves’

Ophthalmopathy - a 1-year Follow-up

Brammen Lindsay Allgemeinchirurgie_731

AP19098BGM Die protektive Rolle von

Thrombozyten-Inhibitoren in der Entstehung Chemotherapie- assoziierter

Fettlebererkrankungen

Stift Anton Allgemeinchirurgie_731

AP15071BGM Evaluation of a specific diagnostic biomarker panel in rectal cancer

Bergmann Michael Allgemeinchirurgie_731

AP15230BGM Prädiktive Marker für das Therapieansprechen bei Rektalkarzinomen

Silberhumer Gerd Allgemeinchirurgie_731

ALT00 Pilot Ullrich Roman Anästhesie, Allgemeine

Intensivmedizin und Schmerztherapie_738 FA738A0809 European Health Data and

Evidence Network Kimberger Oliver Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738 FA738A2101 Feasibility of a neuromuscular

electrostimulation device for mechanical thromboprophylaxis in ICU patients

Wiegele Marion Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

FA738A2701 NCT 02968823 Windpassinger

Marita Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738 AP00974OFF Die Glykokalyx bei Patienten mit

COVID-19. Eine Pilotstudie Schiefer Judith Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738 FA738A0808 Association of Intraoperative

Hypotension and Postoperative Outcomes: A Retrospective Database Analysis

Kimberger Oliver Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

(3)

FA738C0703 Argatroban Monitoring in kritisch kranken Patienten: Evaluierung eines neuen Ecarin basierten Bedside-Test

Steinlechner

Barbara Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738 FA738A1309 A multicenter, randomized,

active controlled, open label, platform trial on the efficacy and safety of experimental

therapeutics for patients with COVID-19

Ullrich Roman Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

FA738A1306 Recombinant human

angiotensin-converting enzyme 2 (rhACE2) as a treatment for patients with COVID-19

Ullrich Roman Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738 FA738A1304 Prospektive, randomisierte Studie

zur Personalisierten Medizin mit Pentaglobin nach einer

interventionellen Fokussanierung bei Peritonitis-Patienten

FA738A1303 Klinischen Prüfung der

pharmakologische Sicherheit und Wirksamkeit des Prüfpräparates AP301 powder for reconstitution for solution for inhalation in Patienten mit pulmonalem Permeabilitätsödem bei Patienten mit mäßigem bis schwerem akutem Atemnotsyndrom (ARDS)

AP19040BGM Protektive

Beatmungseinstellungen durch reduzierte Atemfrequenz und niedrige Atemzugsvolumina bei PatientInnen mit akutem Atemnotsyndrom (ARDS) und veno-venöser extrakorporaler Membranoxygenierung (VV- ECMO): eine prospektive, randomisiert kontrollierte, klinische Studie.

König Sebastian

Lukas Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

FA738A2601 Cholchicine for the Prevention of

Perioperative Atrial Fibrillation Kabon Barbara Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738 FA738A2402 Multinational, , retrospective

observational study to evaluate coagulation changes and the influence of antithrombin III treatment in patients with severe COVID-19 infection

Gratz Johannes Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie_738

APP34191FW Epigenetic drug valproic acid in

vertebrate aging Pusch Oliver Anatomie und

Zellbiologie_310 FA613A0504 Roles of Epitranscriptomics in

Diseases "ROPES" Jantsch Franz-

Michael Anatomie und

Zellbiologie_310

(4)

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparatorcontrolled Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion

Sacu Gülhan Stefan Augenheilkunde und Optometrie_746

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparatorcontrolled Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Macular Edema Secondary to Branch Retinal Vein Occlusion

FA746A1633 An open-label multi-cohort Phase 1b/2 study of derazantinib and atezolizumab in patients with urothelial cancer expressing activating molecular FGFR aberrations

FA746A2503 Automated DR-screening should help make or keep reliable DR- screening available to most patients with diabetes mellitus in the challenging context of increasing patient numbers and constrained or shrinking healthcare budgets.D

Gerendas Bianca Augenheilkunde und Optometrie_746

APKLI670FW A multimodal approach towards an objective assessment of macular function at retinal and cortical levels

Ritter Markus Augenheilkunde und Optometrie_746

FA746A3106 Educational Grant Leydolt Christina Augenheilkunde und Optometrie_746 FA746A3105 Cell precipitates and

biocompatibility study of two different (hydrophobic acrylic) intraocular lenses: IOL XY1 vs.

IOL XY1A

Leydolt Christina Augenheilkunde und Optometrie_746

FA662A0601 Belastungserhebung von Einstreu-Sentinel-Tieren anhand 3 verschiedener Parameter

Tillmann Katharina

Elisabeth Biomedizinische Forschung_308 FA662A0402 Computational and Experimental

Drug Repurposing Podesser Bruno Karl Biomedizinische Forschung_308 FA662A0701 Osteokonduktive, anti-

mikrobielle Beschichtungen für komplikationsfreie Polymer-3D- gedruckte Gesichts-lmplantate

Kapeller Barbara Biomedizinische Forschung_308

FA727A0611 PROCESS TRANSFER AND

VALIDATION OF APN401 Worel Nina Blutgruppenserologie und Transfusionsmedizin_727 APF06102FW Dissecting cell type-specific

chromatin dynamics driven by oncogenic JAK-STAT signaling.

Farlik-Födinger

Matthias Dermatologie_722

(5)

FA722C1208 Epidemiology of Hereditary Angioedema and its Subtypes in Austrian Registry of Bradykinin- mediated Angioedama

Kinaciyan Tamar Dermatologie_722

APKLI716FW CUTANEOUS AUTOIMMUNE

PHENOMENA IN HIV+ PATIENTS Schuster

Christopher Dermatologie_722 FA722C0436 A Phase 3, Randomized, Double-

Blind Study to Evaluate the Safety and Efficacy of Switching from a Regimen of Dolutegravir and Either Emtricitabine/Tenofovir Alafenamide or

Emtricitabine/Tenofovir Disoproxil Fumarate to a Fixed Dose Combination of Bictegravir/

Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Subjects who are Virologically Suppressed” (together with any amendments thereto, which are incorporated herein by reference, the “Protocol”)

Rieger Armin Dermatologie_722

AP19074BGM Identifikation von MicroRNAs als Tumormarker für das kutane Plattenepithelkarzinom (miRNA- cSCC Study).

Geusau Alexandra Dermatologie_722

FA722A0505 A randomized, subject and investigator blinded, placebo- controlled and multi-center platform study, to assess efficacy and safety of different

investigational drugs in patients with moderate to severe hidradenitis suppurativa

Jonak Constanze Dermatologie_722

AP18130BGM ssRNAseq Untersuchung von innate lymphoid cells bei Patienten mit atopischer Dermattis und gesunden Personen.

Stingl Georg Dermatologie_722

FA722C1413 A Prospective, Multicenter, Long- Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis.

Bangert Christine Dermatologie_722

FA722C1405 A Multicenter, Randomized, Double-Blind, Placebo-ontrolled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Patients with Moderate to Severe Atopic Dermatitis.

FA722C1409 A Phase 3 Randomized, Placebo- Controlled, Double-Blind Study to Evaluate Upadacitinib in

Combination with Topical Corticosteroids in Adolescent und Adult Subjects with

(6)

FA722C1408 A multi-center, randomized, double-blind, active and placebo- controlled study ti investigate the efficacy and safety of ligelizumab (QGE031) in the treatment of Chronic

Spontaneous Urticaria (CSU) in adolescents and adults

inadequately controlled with H1- antihistamines.

AP00833OFF Immunomicrobiome - A new model for tissue repopulation of immune cells and microbes in humans.

Stingl Georg Dermatologie_722

FA722A1301 SPORE in Cervical Cancer Kirnbauer Reinhard Dermatologie_722 FA722B1136 A Phase 3 Randomized, Placebo-

controlled Trial to Evaluate the Safety and Efficacy of

Pembrolizumab (MK-3475) and Lenvatinib (E7080/MK-7902) Versus Pembrolizumab Alone as First-line Intervention in Participants with Advanced Melanoma (LEAP-003)” (MK-7902- 003-Site number 0778)

Höller Christoph Dermatologie_722

AP00972OFF Deciphering the pathogenic immune infiltrate in atopic dermatitis subtypes.

Brunner Patrick Dermatologie_722

Projekttitel Flatzbauer Susanne Forschungsservice, Wissenstransfer und Internationales_114 A PHASE III, MULTICENTER,

RANDOMIZED, OPEN-LABEL STUDY COMPARING

ATEZOLIZUMAB (ANTI−PD-L1 ANTIBODY) IN COMBINATION WITH ADJUVANT

ANTHRACYCLINE/TAXANE-BASED CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE IN PATIENTS WITH OPERABLE TRIPLE-NEGATIVE BREAST CANCER

Singer Christian Frauenheilkunde_751

FA751C0645 Randomisiert kontrollierte Studie: Intraoperative

Anwendung von HaemoCerTM bei brusterhaltender Chirurgie zur Reduktion des

postoperativen Drainagevolumens

FA751B0701 Ex-vivo Behandlung von Vaginalproben von Patientinnen mit bakterieller Vaginose mit dem Gardnerella-spezifischen Endolysin PM-477

Farr Alex Frauenheilkunde_751

FA751C0513 Gene Expression in Fat Tissue of PCOS Patients Translational Research Austria

Wenzl René Frauenheilkunde_751

(7)

FA751C0130 A PHASE III, MULTICENTER, RANDOMIZED, STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COMBINATION WITH

PACLITAXEL, CARBOPLATIN, AND BEVACIZUMAB FOR PATIENTS WITH NEWLY DIAGNOSED STAGE III/IV OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER_RO5541267

Reinthaller

Alexander Frauenheilkunde_751

FA751D0711 A randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus placebo and elagolix 150 mg in women with symptomatic endometriosis

Egarter Hans

Christian Frauenheilkunde_751

FA751C0517 A randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus placebo and elagolix 150 mg in women with symptomatic endometriosis

Wenzl René Frauenheilkunde_751

FA751C0662 Germline BRCAness in patients with ovarien and breast cancer with and without family history

AP00875OFF A protein panel for the early detection of type II ovarian cancer

Obermayr Eva Frauenheilkunde_751

FA744C0105 APrevent Vocal Implant System (VOIS) zur anpassbaren Behandlung der einseitigen Stimmbandlähmung (UVFP) - eine offene, nicht randomisierte Pilotstudie

Schneider-Stickler

Berit Hals-, Nasen- und

Ohrenkrankheiten_744

Clinical Evaluation of Advanced Analytics Using Retrospective Analysis of Log Files

Schlöglhofer

Thomas Herzchirurgie_732 MAIA MIC AKE Plattform Andreas Martin Herzchirurgie_732 FA732A0201 Aortic Emergency Device Osorio Emilio Herzchirurgie_732 FA731C2301 Pumpe für ECCO2R - Anteil

Herzchirurgie Granegger Marcus Herzchirurgie_732 FA732A0101 ARIES HM3 Antiplatelet Removal

and Hemocompatlbility Events with the Heartmate 3 Pump (CRD_971 ARIES)

Zimpfer Daniel Herzchirurgie_732

(8)

AP15114BGM Cell-free donor DNA as a predictor of rejection and cardiac allograft vasculopathy;

Zirkulierende zellfreie Spender- DNA als Prädiktor für Abstoßung und Graft-Vasculopathie in herztransplantierten Patienten

Andreas Martin Herzchirurgie_732

FA731C1802 Europäische multizentrische Registerstudie für Patienten zur Beurteilung von Ergebnissen bei Bypass-Operationen von

Koronararterien: Behandlung von vaskulären Gefäßstützen mit DuraGraft, einem neuen Hemmstoff von

Endotheleinrissen

Sandner Sigrid Herzchirurgie_732

API03778FW Human Nicotinic Receptor Polymorphisms in Synaptic Pathology

Scholze Petra Hirnforschung_360

FA629A0301 EU Targeted Cell Recruitment During Organogenesis And Regeneration: Glia Makes The Tooth

Adameyko Igor Hirnforschung_360

FA620A0201 Coordinating Investigator Fee Kasper Siegfried Hirnforschung_360 FA684A0104 Evaluating glial and neuronal

GFAP, MCP-1 and NfL as blood biomarkers for onset and disease severity in cerebral

adrenoleukodystrophy”

Berger Johannes Hirnforschung_360

Brustkrebsakademie Preusser Matthias Innere Medizin I_711 FA712A0707 Auswirkung des Konsums

xanthohumolhaltigen

Nahrungsergänzungsmittels aud DNA-Stabilität in humanen Lymphozyten

Knasmüller

Siegfried Innere Medizin I_711

APCOV41BGM Characterization of extracellular vesicles and fibrinolytic

impairment in coronavirus disease 2019 (COVID-19) patients

Eichinger-

Hasenauer Sabine Innere Medizin I_711

AP00918OFF CRISPR/Cas9 based genome-wide screen for the identification of novel factors driving evolution of drug resistance in a breast cancer organoid model

Csiszar Agnes Innere Medizin I_711

A multicenter, Phase 2a, open- label, non-randomized study evaluating the efficacy, safety, and tolerability of BIVV020 in adults with persistent/chronic immune thrombocytopenia (ITP)“

- PDY16894 mit der Substanz BIVV020

Pabinger Ingrid Innere Medizin I_711

(9)

FA711C0690 A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF

OBINUTUZUMAB AND GDC-0199 (ABT-199) VERSUS

OBINUTUZUMAB AND

CHLORAMBUCIL IN PREVIOUSLY UNTREATED PATIENTS WITH CLL AND COEXISTING MEDICAL CONDITIONS

Jäger Ulrich Innere Medizin I_711

FA711C1057 Phase I, open label, multicenter, dose escalation study of YTB323 in adult patients with CLL/SLL and DLBCL

AP00976OFF Antimicrobial Effects of

Antiplatelet Drugs Traby Ludwig Innere Medizin I_711 FA711A0307 Delivering ECMO-BIOMARKER – a

groundbreaking ICT-enabled ECMO Biomarker system providing clinicians with bedside decision support for better care and reduced costs of severe ICU patients’ — ‘ECMO-BIOMARKER’

Watzke Herbert Innere Medizin I_711

UE71106010 Personalkostenförderung Studieninfrastruktur

Jäger Ulrich Innere Medizin I_711 APP29712FW Elucidating hepatic OATP-ligand

interactions and selectivity

Szakacs Gergely Innere Medizin I_711

FA711C0690 A PROSPECTIVE, OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III TRIAL TO COMPARE THE EFFICACY AND SAFETY OF A COMBINED REGIMEN OF

OBINUTUZUMAB AND GDC-0199 (ABT-199) VERSUS

OBINUTUZUMAB AND

CHLORAMBUCIL IN PREVIOUSLY UNTREATED PATIENTS WITH CLL AND COEXISTING MEDICAL CONDITIONS

FA711B0907 DISEASE-DRUG MATCHING AND BIOMARKER DISCOVERY STUDY USING Allcyte's

PHARMACOSCOPY

Preusser Matthias Innere Medizin I_711

FA711B0708 An Open Label, Randomized, Two Arm Phase III Study of Nivolumab in Combination with Ipilimumab versus Extreme Study Regimen (cetuximab +

cisplatin/carboplatin +

fluorouracil) as First Line Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

(10)

FA711B0601 "A Phase 3 Clinical Trial of Pembrolizumab (MK-3475) in First Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK3475-048)"

FA711B0542 A Phase 3, Multicenter, Open- label, Randomized Study of nab- Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic Adenocarcinoma

FA711B0967 a phase III, multicenter, randomized, open-label, controlled study to evaluate the efficacy, safety and

pharmacokinetics of Atezolizumab given in

combination with Cabozantinib versus Docetaxel monotherapy in patients with metastatic non- small cell lung cancer previously treated with an anti-PD-L1/PD-1 antibody and platinum-

containing chemotherapy

FA711C1309 A Phase 2, Open-Label, Repeat Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Proof-of- Concept of Intravenous ANX005 in Subjects with Warm

Autoimmune Hemolytic Anemia

FA711C1308 A Study to Evaluate the Complement Signature of Subjects with Warm Autoimmune Hemolytic Anemia

FA711C1307 M20-178: A Randomized, Open- Label, Phase 3, Study Evaluating Efficacy and Safety of Navitoclax in Combination with Ruxolitinib Versus Best Available Therapy in Subjects with Relapsed/

Refractory Myelofibrosis (TRANSFORM-2)

FA711C1306 M16-191: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib in Subjects with Myelofibrosis (TRANSFORM- 1)

FA711B0906 Expression/methylation of cancer testis antigens may predict response to

pembrolizumab in non small cell lung cancer patients

(11)

FA711B0577 Phase III post-neoadjuvant study evaluating palbociclib, a Cyclin- Dependent Kinase (CDK)4/6 inhibitor in primary hormone- receptor-positive, HER2-negative breast cancer patients with high relapse risk after standard neoadjuvant treatment

FA711B0565 A Randomized, Double-Blind, Placebo-Controlled, Phase IIIb Study of the Efficacy and Safety of Continuing Enzalutamide in Chemotherapy Naïve Metastatic Castration Resistant Prostate Cancer Patients Treated with Docetaxel plus Prednisolone Who Have Progressed on

Enzalutamide Alone (218698 Prot. 9785-MA-1001)

FA711C1033 A phase 3 multicenter, randomized, prospective, open- label trial of standard

chemoimmunotherapy (FCR/BR) versus rituximab plus venetoclax (RVe) versus obinutuzumab (GA101) plus venetoclax (GVe) versus obinutuzumab (GA101) plus ibrutinib plus venetoclax (GIVe) with previously untreated chronic lymphocytic leukemia (CLL) without Del(17p) or TP53 mutation

FA711C0661 Registry and Biobank for the collection of clinical data and biomaterial from adult ALL patients (AGMTALLReg)

FA711C1012 Einsatz von Lenalidomid (Revlimid®) beim unbehandelten nicht transplantierbaren Multiplem Myelom unter Praxisbedingungen

FA711D0308 Praxisnahe Beobachtungsstudie zu Zavicefta® (Ceftazidim- Avibactam) zur Charakterisierung von Anwendungsmustern, Wirksamkeit und Sicherheit - EZTEAM Studie

Burgmann Heinz Innere Medizin I_711

FA711D0305 CAPNETZ - Epidemiologische Studie und Aufbau einer Biobank zur ambulant erworbenen Pneumonie

FA711D0311 Emergency-Call zur Erforschung von COVID-19 im Zuge des Ausbruchs von Sars-CoV-2

(12)

FA711C1201 Laboratory measurements for monitoring the treatment of patients with hemophilia treated with FVIII-, FIX-replacement therapies and non-

factor therapeutics

Königsbrügge

Oliver Innere Medizin I_711

FA711B0908 CA224-060: A Randomized, Open-label, Phase II Clinical Trial of Relatlimab (anti-LAG-3) plus Nivolumab in Combination with Chemotherapy Versus Nivolumab in Combination with

Chemotherapy as First-Line Treatment in Patients with Gastric or Gastroesophageal Junction Adenocarcinoma

AP17125BGM Messung von

Medikamentenkonzentrationen während simulierter

kontinuierlicher hochdosis Nierenersatztherapie

Vossen Matthias Innere Medizin I_711

AP00975OFF The mosquito viral microbiome – matching human disease of unknown origin with novel viruses

Thannesberger

Jakob Innere Medizin I_711

FA711C0644 MPN Mutational Analysis to unravel molecular patterns in early stages of disease, during treatment (incl. Ruxolitinib) and leukemic transformation

FA711C0387 Novartis CETB115BIC03: ERMES - European Real world

observational study on Management strategies with Eltrombopag in ITP to detect outcome predictive factorS

FA711C1305 A phase 3 multicenter, randomized, prospective, open- label trial of ibrutinib

monotherapy versus fixed- duration venetoclax plus obinutuzumab versus fixed duration ibrutinib plus venetoclax in patients with previously untreated chronic lymphocytic leukemia (CLL)

FA711C1303 An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of TL-895 Combined with KRT-232 in Subjects with Relapsed/Refractory (R/R) FLT3+

Acute Myeloid Leukemia (AML)

FA711B0739 A Phase III Study of BBI-608 plus nab-Paclitaxel with Gemcitabine in Adult Patients with Metastatic Pancreatic Adenocarcinoma

(13)

AP19013BGM Kontaktaktivierung in

extrakorporaler Kreislauf- und Lungenunterstützung (ECMO)

Buchtele Nina Innere Medizin I_711

FA711B0519 EVA (evaluation of Votrient® in angiosarcoma): Einarmige, multizentrische offene Phase-II- Studie zur Überpürfung der Wirksamkeit der Kombination von Paclitaxel mit Pazopanib bei fortgeschrittenen und

rezidivierten Angiosarkomen

FA711B0725 A randomized, open label, multicenter study of Cabazitaxel versus an Androgen Receptor (AR)-targeted agent (abiraterone or enzalutamide) in mCRPC patients previously treated with Docetaxel and who rapidly failed a prior AR-targeted agent

FA711C1051 Longitudinal investigation of in vitro and ex vivo thrombin generation in patients with venous thromboembolism

FA711C1053 Eine randomisierte, multizentrische, offene, pharmakokinetische Phase-III- Nichtunterlegenheitsstudie im Parallelgruppendesign zu subkutan vs. intravenös verabreichtem Ravulizumab bei erwachsenen Patienten mit paroxysmaler nächtlicher Hämoglobinurie, die aktuell mit Eculizumab behandelt werden

FA711D0302 Investigating the role of Actinomyces spp. In

Osteonecrosis of the jaw – a pilot study

FA711C1304 Eine multizentrische, offene Phase-III-Langzeitstudie zur Beurteilung der Sicherheit und Wirksamkeit von intravenös verabreichtem Efgartigimod (ARGX-113) 10 mg/kg bei erwachsenen Patienten mit primärer

Immunthrombozytopenie

FA711A0310 CAR-T-Zell Postmarketingstudien der European Blood and Marrow Transplantation Society (EBMT)

Watzke Herbert Innere Medizin I_711

(14)

FA711C0683 A PHASE 2 MULTICENTER, OPEN- LABEL STUDY TO DETERMINE THE EFFICACY AND SAFETY OF POMALIDOMIDE (CC-4047) IN COMBINATION WITH LOW-DOSE DEXAMETHASONE IN SUBJECTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND MODERATE OR SEVERE RENAL IMPAIRMENT INCLUDING SUBJECTS UNDERGOING HEMODIALYSIS

FA712A0708 Untersuchungen

gesundheitlicher Auswirkungen und der zugrunde liegenden molekularen Mechanismen durch einen gallussäurehaltigen Pflanzenextrakt

Knasmüller Siegfried

Innere Medizin I_711

FA711C1084 Supporting CLL Patients using the Advanced Symptom Management System (ASYMS) Remote Technolog

FA711C1079 ESMART: Supporting Myeloma Patients using the Advanced Symptom Management System (ASYMS) Remote Technology

AP20064BGM Cross-Talk of Plasma-Virome and Innate Immune System in Haematopoietic Stem Cell Transplant Recipients

Thannesberger Jakob

Innere Medizin I_711

FA711C0386 A multinational, prospective, open labelled, non-controlled, non-interventional post-

authorisation study of turoctocog alfa pegol (N8-GP) during long- term routine prophylaxis and treatment of bleeding episodes in patients with haemophilia A

FA712A1205 Exploratory study of health related physiological and biochemical parameters to identify simple, robust and relevant biomarkers for therapeutic interventions for PTSD patients

Holzmann Klaus Innere Medizin I_711

FA711B0966 a randomized, double-blind placebo-controlled, phase-3 study of Debio 1143 in

combination with platinum-based chemotherapy and standard fractionation intensity-modulated radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck, suitable for definitive

chemotherapy (TrilynX)

(15)

FA711B0963 an open-label, randomised, multicenter, phase-III study of Iriontecan liposome injection, Oxiplantin, 5-

flurouracil/Leucovorin versus Nab-Paclitaxel plus Gemcitabine in subjects who have previously received chemotherapy for matastatic Adenocarcinoma of the pancreas

FA711B0964 a phase-II, open-label,

randomized, parallel arm study of NIS793 (with and without Spartalizumab) in combination with SOC chemotherapy Gemcitabine/nab-Paclitaxel, and Gemcitabine/nab-Paclitaxel alone in first-line metastatic pancreatic ductal adenocarcinoma (mPDAC) - interner Studiencode

CNIS793B12201

FA711B0965 eine retrospektive, nicht-

interventionelle Studie zur Studie zur Erstlinienbehadlung von Patienten mit BRAFV600E mutiertem metastasiertem Darmkrebs

FA711B0962 a phase-III, randomized, double- blind, placebo-controlled study of Atezolizumab with or without Tiragolumab (Anti-Tigit antibody) in patients with unresectable locally advanced Esophaegeal squamous cell carcinoma

FA712A1104 Albuplatin Heffeter Petra Innere Medizin I_711

FA712A0707 Auswirkung des Konsums xanthohumolhaltigen

Nahrungsergänzungsmittels aud DNA-Stabilität in humanen Lymphozyten

Knasmüller

Siegfried Innere Medizin I_711

UE71106014 Beitrages zu den Kosten eines

Study Coordinators Jäger Ulrich Innere Medizin I_711 FA711C1050 Comprehensive genomic

profiling and next generation functional drug screening for patients with aggressive haematological malignancies:

next generation personal medicine

FA711C1097 eSMART: Verlaufsuntersuchung von Lebensqualität bei

Krebspatienten der Abteilung für Hämatologie mittels der

psychoonkologischen Basisdiagnostik

(16)

FA711C1301 AERN - Abscopal Effect of Radiotherapy and Nivolumab in anti-PD1 Pretreated Relapsed or Refractory classical Hodgkin Lymphoma - An international multicenter Phase II trial

FA711B0961 a multicenter, double-blind, randomized, controlled study of M7824 with concurrent

chemoradiation, followed by M7824 versus concurrent chemoradiation plus placebo, follwed by Durvalumab in participants with unresectable stage-III non-small cell lung cancer

FA711C1098 A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Efgartigimod (ARGX-113) 10 mg/kg Intravenous in Adult Patients with Primary Immune Thrombocytopenia

FA711C1099 Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy (Call H2020-JTI-IMI2-2019-18- two-stage; Agreement Number 945393 „T2EVOLVE“)

AP00805OFF Mutated B/EBP Binding Sites in

the -14kb URE of PU.1 Kazianka Lukas Innere Medizin I_711 Ertugliflozin to Reduce

Arrhythmic burden in ICD/CRT patientS (ERASe-Trial) – a phase III Study

Gwechenberger

Marianne Innere Medizin II_714

Liposomal doxorubicin

attenuates cardiotoxicity Pavone-Gyöngyösi

Mariann Innere Medizin II_714 Durchführung einer

retrospektiven multizentrischen Erhebung zur Indikation und Wirksamkeit von Cangrelor bei perkutanter Koronarintervention

Siller-Matula Jolanta Innere Medizin II_714

FA714C0707 Post-Market Clinical follow-up Studie mit dem ASPIREX®S Endovascular System zur Untersuchung der Sicherheit und Effektivität bei der Behandlung von DVT Patienten und speziellen Patientengruppen

Schlager Oliver Innere Medizin II_714

FA714B3106 DER NUTZENVON MICROCOR (μCor) BEI AMBULANTER DEKOMPENSIERTER HERZINSUFFIZIENZ (BMAD- Behandlung)

Kastner Johannes Innere Medizin II_714

APKLI700FW Echocardiographic changes in

heart-healthy diabetics Hülsmann Martin Innere Medizin II_714

(17)

FA714B4210 EURO SHOCK - eine Studie über die frühzeitige Intervention mit der extrakorporalen Membran- Oxygenierung (ECMO) bei Patienten mit kardiogenem Schock

Hengstenberg

Christian Innere Medizin II_714

Impact of plasminogen binding on innate immune cell function in atherosclerosis

Wojta Johann Innere Medizin II_714

FA714D0801 “A Multicenter, Double Blind, Randomized, Controlled Study of M7824 with Concurrent

Chemoradiation Followed by M7824 versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants with Unresectable Stage III Non-small Cell Lung Cancer

Gompelmann

Daniela Innere Medizin II_714

AP15214BGM Activity-impairing single nucleotide polymorphism in the deoxyribonuclease gene lead to high neutrophil extracellular trap burden and increased incidence of ST-elevation myocardial infarction

Mangold Andreas Innere Medizin II_714

FA714B2713 Repatha NIS Bergler-Klein Jutta Innere Medizin II_714 FA714B2012 Alprostadil infusion in Heart

Failure Patients Hülsmann Martin Innere Medizin II_714 FA714B3801 NOAH - Afnet 6: Non-vitamin K

antagonist Oral anticoagulants in patients with Atrial High rate episodes

Bergler-Klein Jutta Innere Medizin II_714

UE71406007 Drittmittelfinanzierung Study

Nurse Lang Irene Innere Medizin II_714

FA714B2004 NT proBNP Selected PreventiON of cardiac eveNts in a populaTion of dIabetic patients without A history of Cardiac disease: a prospective randomized trial (PONTIAC II study)

Hülsmann Martin Innere Medizin II_714

FA714B4002 Prospective national

transthyretin cardiac amyloidosis registry

Duca Franz Innere Medizin II_714

FA714B5001 Auslandsstipendium

Rhythmologie Stojkovic Stefan Innere Medizin II_714 FA714D0701 A randomised, double-blind,

placebo-controlled parallel group study in IPF patients over 12 weeks evaluating efficacy, safety and tolerability of BI 1015550 taken orally

Gysan Maximilian Innere Medizin II_714

FA714B2011 Randomized Evaluation and Verification of Ventricular Enhancement (REVIVE-HF)

Hülsmann Martin Innere Medizin II_714

(18)

FA714C0605 Eine dreiteilige, einarmige, offene Studie zur Bewertung der Wirksamkeit, Sicherheit und Pharmakokinetik von Evinacumab bei pädiatrischen Patienten mit homozygoter familiärer Hypercholesterinämie

Willfort-Ehringer

Andrea Innere Medizin II_714

FA714B4902 Eine randomisierte,

doppelblinde, adaptive Phase- II/III-Studie mit GSK3359609 oder Placebo in Kombination mit Pembrolizumab zur

Erstlinienbehandlung von PD-L1 positiven rezidivierten oder metastasierten Kopf- und Hals- Plattenepithelkarzinomen (INDUCE-3)l

Kastl Stefan Innere Medizin II_714

AP20070BGM Heart failure with preserved ejection fraction in patients after successful aortic valve

replacement

Schrutka Lore Innere Medizin II_714

FA714B0370 An Open Trial Evaluating the Safety of an Implantable Pump in the Management of Intravenous Trepostinil Therapy in Patient with Pulmonary Arterial Hypertension (ProPat A)

Lang Irene Innere Medizin II_714

FA714B0364 Edoxaban versus

Versorgungsstandard und deren Wirkungen auf die klinischen Ergebnisse bei Patienten mit Vorhofflimmern nach erfolgtem Kathetergestütztem

Aortenklappenersatz (ENVISAGE TAVI-AF)

Lang Irene Innere Medizin II_714

FA714B0532 MHH Pavone-Gyöngyösi

Mariann Innere Medizin II_714 AP00973OFF Novel Diagnostic Markers for

Intestinal Complications in Critically Ill Patients

Krychtiuk

Konstantin Innere Medizin II_714 A Phase 3, Multicenter,

Randomized, Efficacy Assessor- Blinded Study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn's Disease Who Have Failed Anti- TNF therapy

Trauner Michael Innere Medizin III_716

FA716E0913 INTIMIC - Dietary Modulation of intestinal microbiota as Trigger of liver health: role of bile acids (Di Mi Liv)

FA716D1403 Schwangerschaftsregister für Patientinnen mit rheumatischen Erkrankungen &

Familienplanung/-Gründung

Mazzucato-Puchner

Antonia Innere Medizin III_716

(19)

AP18087BGM Propensity for calcification in serum as a predictor for mortality and cardiovascular events in patients wih chronic heart failure

Bojic Marija Innere Medizin III_716

APP30830FW Adaptation to hypoxia: a template to fight metabolic disease

Fürnsinn Clemens Innere Medizin III_716

APCOV32BGM Investigating the prognostic impact of the renin-angiotensin- aldosterone-system activity in patients hospitalized for COVID- 19 infektion

Wolf Peter Innere Medizin III_716

APCOV27BGM Pharmakologische Renin- Angiotensin System (RAS)- Blockade und der RAS

"Fingerabdruck" bei COVID-19

Hecking Manfred Innere Medizin III_716

AP19023BGM Crossreactivity as a generator of alloreactive T cells in kidney transplant recipients

Gualdoni Guido Innere Medizin III_716

FA716E0987 A PHASE 2B, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED DOSE- RANGING STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF PF- 06480605 IN ADULT

PARTICIPANTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

FA716E0986 Investigation of the potency, duration and efficacy of LNP- delivered human ABCB11 mRNA to a mouse model of PFIC2

FA716E0949 Consultancy Agreement Boehringer Ingelheim International GmbH

FA716E0944 Efficacy of sGC agonists in biliary cirrhosis and portal hypertension

FA716E0558 A multicentre, open label study of CP-690,550 in subjects with moderate to severe ulcerative colitis

FA716E0985 Targeting GSK3𝛂𝛂 with siRNA to correct Fragile X phenotypes observed in FMR1-/y mice

FA716E0843 AN OPEN-LABEL EXTENSION AND SAFETY MONITORING STUDY OF PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE PREVIOUSLY ENROLLED IN THE ETROLIZUMAB PHASE III PROTOCOL GA29144

An open-label extension and safety monitoring study of patients with moderately to

(20)

etrolizumab phase III protocol GA29144

Rheumatic Diseases and Reproduktion - Austrian Register RHEPRO

Mazzucato-Puchner Antonia

Innere Medizin III_716

FA716C0820 Otsuka ADPKD Bone 19317 Sunder-Plaßmann Gere

FA716C0816 FOS Sunder-Plaßmann

Gere Innere Medizin III_716 FA716E0982 A Randomized, Multi-center,

Double-blinded, Placebo- controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination with Trans-arterial

ChemoEmbolization (TACE) in Patients with Intermediate-stage Hepatocellular Carcinoma (HCC)

APKLI904FW Nicht-invasive Marker der Muskelstoffwechsel-Flexibilität (Non-invasive markers of muscular metabolic flexibility)

Krssak Martin Innere Medizin III_716

APCOV04BGM Monitoringsystem der Resilienz des Gesundheitssystems mit besonderer Berücksichtigung der österreichweiten strukturellen Kapazitäten Projekt-Nummer:

CoVid004

Kautzky-Willer

Alexandra Innere Medizin III_716

FA716E0984 Elimination of Hepatitis C in Eastern Austria

Trauner Michael Innere Medizin III_716 FA716E0983 INTEGRIN SIGNALING IN LIVER

FIBROSIS Trauner Michael Innere Medizin III_716

FA716D1302 Targeting the type I interferon (IFN) receptor in rheumatoid arthritis (RA) patients with a high IFN signature – A multicenter, randomised, double-blind, placebo-controlled Phase 2A/

proof-of-concept study to evaluate the efficacy and safety of an intravenous treatment regimen of 300 mg Anifrolumab versus placebo in patients with moderately to severely active RA who did not respond to

biological disease-modifying anti-rheumatic drugs (bDMARDs) and who have a high IFN- signature

Smolen Josef Innere Medizin III_716

(21)

FA716D0243 the phenotypes of patients with rheumatoid arthritis (RA) who are responsive to IL-17 inhibition and have failed to attain a significant response to molecules targeting other inflammatory pathways

Smolen Josef Innere Medizin III_716

FA716E0113 Qualitätszertifikat

Vorsorgekoloskopie Trauner Michael Innere Medizin III_716 FA716C1013 Effect of etelcalcetide on cardiac

hypertrophy in hemodialysis patients - a randomized controlled trial

Oberbauer Rainer Innere Medizin III_716

FA716B1002 Eine randomisierte, doppelblinde, Placebo kontrollierte Studie zur Bewertung der Sicherheit und Wirksamkeit von Crinecerfont (NBI-74788) bei erwachsenen Patienten mit klassischem kongenitalem adrenogenitalem Syndrom, gefolgt von einer unverblindeten Behandlung

Kiefer Florian Innere Medizin III_716

FA716B0619 A randomized, placebo-

controlled, double-blind, parallel- group, multicenter combined Phase 2a/2b study to assess the efficacy and safety of BAY 1817080 in patients with diabetic neuropathic pain

Kautzky-Willer Alexandra

AP00742OFF Wissenschaftspreis der ÖGGH Evstatiev Rayko Innere Medizin III_716 AP15193BGM Longitudinaler Verlauf der

inflammatorischen Antwort und der epithelialen Integrität bei Neonaten mit Nekrotisierender Enterokolitis

Benkö Thomas Kinder- und

Jugendchirurgie_730

FA781B2201 Mein Logbuch - Ich kenne mich

aus! Weiler-Wichtl Liesa Kinder- und

Jugendheilkunde_781 nnovativer Intraossär-Bohrer zur

sicheren Anwendung im akuten Kleinkind- und Neugeborenen- Notfall

Schwindt Eva Kinder- und

Jugendheilkunde_781

A phase IIIb, multcenter, open- label, single-arm study to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of subcutraneous Emicizumab in paients from birth to 12 months of age with hemophilia A without inhibitors

Male-Dressler

Christoph Kinder- und

Jugendheilkunde_781

(22)

FA781F1302 Eine offene Studie der Phase III zur Beurteilung der langfristigen Sicherheit und Wirksamkeit der VX 445 Kombinationstherapie bei Patienten mit zystischer Fibrose, die homozygot oder heterozygot für die F508del-Mutation sind

Dehlink Eleonora Kinder- und

Jugendheilkunde_781

UE78106015 NF Forscherwerkstatt Pletschko Thomas Kinder- und

Jugendheilkunde_781 FA781F1601 Newborn Screening for Spinal

Muscular Atrophy in Austria Zeyda Maximilian Kinder- und

Jugendheilkunde_781 FA781F1602 Pilot for Austrian SMA Newborn

Screening Zeyda Maximilian Kinder- und

Jugendheilkunde_781 FA781G0302 Kindgerechte

Informationsvermittlung bei JIA Seferagic Sanja Kinder- und

Jugendheilkunde_781 FA781G0110 MAPE2 - Vorbereitung einer

klinischen Peritonealdialyse Studie

Aufricht Christoph Kinder- und

Jugendheilkunde_781 APCOV29BGM LAMASPiT - Pilotstudie zum

longitudinalen Screening für nCoV Infektionen bei asymptomatischem oder mild symptomatischem Personal in einer pädiatrischen

Tertiärversorgungs-Klinik

Raimann Adalbert Kinder- und

Jugendheilkunde_781

UE78106017 Durchführung von studentischen Sitzwachen im Rahmen des § 49 Abs 2 ÄrzteG an der Epilepsie- Monitoring-Unit bei PatientInnen mit EEG Monitoring

Berger Angelika Kinder- und

Jugendheilkunde_781

FA781F1010 Eine dreiteilige, einarmige offene Studie zur Bewertung der Wirksamkeit, Sicherheit und Pharmakokinetik von Evinacumab bei pädiatrischen Patienten mit homozygoter familiärer Hypercholesterinämie

Greber-Platzer

Susanne Kinder- und

Jugendheilkunde_781

FA781D0444 Multizentrische, offenen Studie zur Untersuchung der

Wirksamkeit und Sicherheit von AOP Landiolol zur Regulierung supraventrikulärer Tachykardien bei pädiatrischen Patienten (LANDI-PED)

Michel-Behnke Ina Kinder- und

Jugendheilkunde_781

FA781D0608 Data collection for Evidence- based Feasibility (EbF) for Bayer’s PASS for Xarelto to treat VTE in term neonates and children up to 2 years (XaPIA study)

Male-Dressler

Christoph Kinder- und

Jugendheilkunde_781

UE78106017 Durchführung von studentischen Sitzwachen im Rahmen des § 49 Abs 2 ÄrzteG an der Epilepsie- Monitoring-Unit bei PatientInnen mit EEG Monitoring

Berger Angelika Kinder- und

Jugendheilkunde_781

(23)

CD10278101 "CD-Labor für Molekulare Stressforschung in der Peritonealdialyse. (“Christian Doppler Laboratory for Molecular Stress Research in Peritoneal Dialysis"")"

Kratochwill Klaus Kinder- und

Jugendheilkunde_781

FA781G0403 Einarmige Studie zu ALXN1210 für die Komplement-Inhibitor- Therapie bei nicht

vorbehandelten kindlichen Patienten mir atypischem hämolytisch-uärmischem Syndrom (aHUS)

Arbeiter Klaus Kinder- und

Jugendheilkunde_781

FA781G0402 Einarmige Studie zu ALXN1210 für die Komplement-Inhibitor- Therapie bei nicht

vorbehandelten erwachsenen und jugendlichen Patienten mit atypischem hämolytisch- urämischem Syndrom (AHUS)

Arbeiter Klaus Kinder- und

Jugendheilkunde_781

FA781G0303 Valentina and the waterslide - a childrens book for

psychoeducation before kidney transplant in children with chronic kidney disease

Seferagic Sanja Kinder- und

Jugendheilkunde_781

FA781F1006 FH-Register - Familiäre

Hypercholesterinämie Greber-Platzer

Susanne Kinder- und

Jugendheilkunde_781 FA781F0207 ALLEVIATE - A novel strategy for

food allergy prevention and treatment

Szépfalusi Zsolt Kinder- und

Jugendheilkunde_781 FA781F0903 EU H2020 KidsAP Rami-Merhar Birgit Kinder- und

Jugendheilkunde_781 AP17194ONB Patientensicherheit in

pädiatrischer

Organersatztherapie und Transplantation (PaSi-POeT)

Böhm Michael Kinder- und

Jugendheilkunde_781

FA781B1502 REcombiant human

Erythropoetin, Epoetin beta, NeoRecormon(C) for the repair of cerebral injury in very preterm infants - a randomized, double- blind, placebo-cotrolled, prospective and multicentre clinical study - EpoRepair

Klebermaß-Schrehof

Katrin Kinder- und

Jugendheilkunde_781

FA781F1005 Testung auf Saure-Lysosomale-

Lipase-Defizienz (LAL-D) Greber-Platzer

Susanne Kinder- und

Jugendheilkunde_781 FA781B2603 Effects of an exclusive human-

milk diet in preterm NEOnates on early VASCular aging risk factors (NEOVASC)

Binder Christoph Kinder- und

Jugendheilkunde_781

AP17627ONB Mutationen bei syndromaler

Makrozephialie Vodopiutz Julia Kinder- und

Jugendheilkunde_781 FA765A0306 MANTR-a - Magersuchtstherapie

für Jugendliche Karwautz Andreas Kinder- und

Jugendpsychiatrie_765

(24)

FA729A0261 A prospective, randomized, open-label, controlled, exploratory trial to investigate the safety and tolerability of topically administeres VZ in healthy male subjects with artificial dermal wounds

Wolzt Michael Klinische Pharmakologie_729

VACCELERATE - European Corona Vaccine Trial Accelerator Platform

Zeitlinger Markus Klinische Pharmakologie_729

FA729A0736 A Phase III, Multinational, Multicenter, Investigator-Masked, Randomised, Active-Controlled Trial, comparing the efficacy and safety of DE-130A (latanoprost 50 μg/ml eye drops emulsion) with Xalatan® (latanoprost 50 μg/ml eye drops solution) in Patients with Open-Angle Glaucoma or Ocular Hypertension over 3-month period, followed by a 12-month follow-up with open-label DE- 130A treatment

Garhöfer Gerhard Klinische Pharmakologie_729

FA729A1044 Synergistic effect of fosfomycin with flucloxacillin against Staphylococcus aureus in vitro and in vivo in an experimental Galleria mellonella model

FA729A1026 PhD Programm im Bereich

"Preclinical and Clinical Research for Drug Development"

APKLI694FW Impact of ABCB1 on neuo-PK of

metoclopramide Langer Claus Oliver Klinische Pharmakologie_729 AP17059BGM Effekt von topischem

Azithromycin auf die

Tränenfilmdicke von Patienten mit Meibomdrüsendysfunktion - Vergleich zur oralen Therapie mit Doxycyclin

Schmidl Doreen Klinische Pharmakologie_729

FA729A1307 An open-label extension study of Etrasimod in subjects with moderately to severely active ulcerative colitis

FA729A1306 A phase 3, randomized, double- blind, placebo-contnrolled, 12- wwek study to assess the efficacy and safety of Etrasimod in subjects with moderately to severely active ulcerative colitis

FA729A1043 A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Monoclonal Antibody VIR-7831 for the Early Treatment of Coronavirus Disease 2019 (COVID-19) in Non-Hospitalized Patients

(25)

FA729A0257 Explorative, retrospektive data analysis: Longitudinal course of pharmacotherapy and health care utilization in patients with Asthma using SABA as-needed versus ICS-based asthma treatment in BURGenland

Wolzt Michael Klinische Pharmakologie_729

FA729A1401 JPND - PET analyses of ABC transporter function for diagnostics and stratification of dementia patients (PETABC)

Langer Claus Oliver Klinische Pharmakologie_729

FA729A1042 First-in-human, open label, placebo-controlled, ascending dose study to assess the safety, tolerability and pharmacokinteics of a single intratympanic injection of AC102 in healthy volunteers

AP19049BGM Accuracy of a bedside urine stripe test on identifying anticoagulation with direct oral anticoagulants in patients admitted to a high-volume- Emergency Department

Schörgenhofer Christian

Klinische Pharmakologie_729

AP19049BGM Accuracy of a bedside urine stripe test on identifying anticoagulation with direct oral anticoagulants in patients admitted to a high-volume- Emergency Department

Schörgenhofer

Christian Klinische Pharmakologie_729

FA729A0159 A phase 2a multiple dose basket trial of the safety, tolerability, and pharmacologic activity of BT200 in patients with hereditary bleeding disorders

Jilma Bernd Klinische Pharmakologie_729

SFB F83: SP3 Metabolic heterogeneity of human

macrophages in intestinal tissues

Haschemi Arvand Labormedizin_793

SFB F83: SP3 Metrabolic heterogeneity of human

macrophages in intestinal tissues

Haschemi Arvand Labormedizin_793

FA793B0114 Testung von Cefiderocol Willinger Birgit Labormedizin_793 API04963FW Role of APRIL in triglyceride

metabolism

Tsiantoulas Dimitrios

Labormedizin_793 FA793A0335 Assay Performance Evaluation on

cobas t 711 analyzer – Factor Assays

Quehenberger Peter Labormedizin_793

FA793A0327 071102 rVWF in Pediatrics Quehenberger Peter Labormedizin_793 AP17882ONB Elektronische Zigaretten -

Einfluss auf Parodontitis und die oropharyngeale Mikrobiota

Camp Iris Labormedizin_793

FA793C0202 SARS-CoV-2 Nachweis mit VERB-

Capture im Vergleich zu Straßl Robert Paul Labormedizin_793

(26)

FA793A0807 Modulation von oxidativem Stress bei

Stoffwechselerkrankungen

Binder Christoph Labormedizin_793

FA793A2002 Murine models for Ropeg interferon alpha treatment of myeloproliferative neoplasms

Kralovics Robert Labormedizin_793

FA793A0806 B cells in Cardiovascular Disease Binder Christoph Labormedizin_793 FA618A0701 Diamond-Blackfan-Anemia Martinez Javier

Augusto Medizinische Biochemie_305 FA605A1004 Teilautomatisierte Testung von

Biosignal Verstärkern Bijak Manfred Medizinische Physik und Biomedizinische Technik_340 FA605A1602 Innovative Training Network

HYBRID - 764458 Beyer Thomas Medizinische Physik und Biomedizinische Technik_340 FA605A1901 Additive Manufacturing for

Medical Research

Moscato Francesco Medizinische Physik und Biomedizinische Technik_340 FA605A0407 EU MIB 667933 Horizon 2020 Drexler Wolfgang Medizinische Physik und

Biomedizinische Technik_340 FA605A1804 Ultra-fast Scalable OCT System

based on a New Photon Detector Leitgeb Rainer Medizinische Physik und Biomedizinische Technik_340 APP28867FW Advanced measurement of

human cardiac metabolism by interleaved 31P and 1H 7T MR

Schmid Albrecht Medizinische Physik und Biomedizinische Technik_340 CD10260502 Christian Doppler Labor für

Okuläre Effekte von Thiomeren Werkmeister Rene

Marcel Medizinische Physik und Biomedizinische Technik_340 FA605A1905 Ink-Based Hybrid Multi-Material

Fabrication Of Next Generation Implants

Moscato Francesco Medizinische Physik und Biomedizinische Technik_340 CD10260501 CD Labor für innovative optische

Bildgebung und deren Translation in die Medizin

Leitgeb Rainer Medizinische Physik und Biomedizinische Technik_340 FA605A0412 Hand-Held OCT Device for

Spaceflight Drexler Wolfgang Medizinische Physik und Biomedizinische Technik_340 FA605A2603 Revealing drug tolerant persister

cells in cancer using contrast enhanced optical coherence andphotoacoustic tomography

Drexler Wolfgang Medizinische Physik und Biomedizinische Technik_340

AP17839ONB Exploring the Survival Benefit of Kidney Transplantation

compared to Maintenance Dialysis in Elderly End Stage Renal Disease Patients - a retrospective Study

Haller Maria

Christine Medizinische Statistik, Informatik und Intelligente Systeme_303

COTIDIANA_2 - Mobile Patient- centred System to Improve Drug Trials and Care of Older-adults with Rheumatic Diseases

Stamm Tanja Medizinische Statistik, Informatik und Intelligente Systeme_303

FA631A0105 Face API Dorffner Georg Medizinische Statistik,

Informatik und Intelligente Systeme_303

(27)

FA602A0108 Robotic ePartner for Memory INnovative activation of People with Dementia

Stamm Tanja Medizinische Statistik, Informatik und Intelligente Systeme_303

FA632A0504 „Effectiveness and safety of Dimethylfumarate in patients with Palmoplantar Pustulosis” - Statistische Auswertung und Analyse

Ristl Robin Medizinische Statistik, Informatik und Intelligente Systeme_303

FA632A0602 Hospital Care following ICU stay

(NutritionDay) Hiesmayr Jörg

Michael Medizinische Statistik, Informatik und Intelligente Systeme_303

FA632A0601 Usage of Parenteral Nutrition in European Hospitals

(NutritionDay)

Hiesmayr Jörg

Michael Medizinische Statistik, Informatik und Intelligente Systeme_303

FA631A0402 AI-driven prediction of novel links from scientific web resources

Samwald Matthias Medizinische Statistik, Informatik und Intelligente Systeme_303

FA631A0401 Untangling and empowering the web of Artificial Intelligence services

Samwald Matthias Medizinische Statistik, Informatik und Intelligente Systeme_303

FA742A0406 Osteokonduktive, anti-

mikrobielle Beschichtungen für komplikationsfreie Polymer-3D- gedruckte Gesichts-Implantate

Russmüller Günter Mund-, Kiefer- und Gesichtschirurgie_742

FA736A0601 A Phase IIB: Randomised, Single- Blind, Safety, Tolerability, Efficacy and Pharmacokinetic Study of NicaPlant in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping

Bavinzski Gerhard Neurochirurgie_736

AP19012BGM Imaging memory networks in temporal lobe epilepsy

Bonelli-Nauer Silvia Neurologie_761

FA761A1129 A phase III, multicenter, randomized, parallel group, double blind, double dummy, active controlled study of Evobrutinib compared with Teriflunomide in participants with relapsing Multiple Sclerosis to evaluate efficacy and safety

Berger Thomas Neurologie_761

European Joint Programme on

Rare Diseases Voigtlaender Till Neurologie_761 FA761A1128 Early versus Late initiation of

direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillation

FA761A1127 Phase 3b open-label, multicenter, safety study of BIIB037

(aducanumab) in subjects with Alzheimer's disease who had previously participated in the Aducanumab studies 221AD103, 221AD301,and 221Abio

(28)

FA761A1126 LETHE - a personalized prediction and intervention model for early detection and reduction of risk factors causing dementia, based on AI and distributed machine learning

AP00907OFF Frühzeitige Neurodegeneration im Kontext maligner

Hirntumoren

Klotz Sigrid Neurologie-Institut_796

FA761A0701 A phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel- group study to evaluate the efficacy and safety of Aducanumab (BIIB037) in subjects with early Alzheimer's Disease

Stögmann Elisabeth Neurologie-Klinik_761

FA761A1101 The effect on blink frequency of a selective blue-filtering photochromic lens in patients with benign essential

blepharospasm

Berger Thomas Neurologie-Klinik_761

FA761A1114 Biomarker in erarly and

preclinical neurological phase of Gaucher's disease

FA761A1105 Gapless ECG-Monitoring in Stroke at high risk for Atrial Fibrillation (GEMS-AF)-Study

FA761A0181 A 12-week double-blind, randomized, multicenter study comparing the efficacy and safety of once monthly subcutaneous 140mg AMG334 against placebo in adult episodic migraine patients who have failed 2-4 porphylactic treatments

FA728A0606 Prehospital cooling of comatose patients after cardiac arrest with a non-invasive, unpowered core body cooling device

Holzer Michael Notfallmedizin_728

Prospective Evaluation of the European Society of Cardiology 0/1h-algorithm`s Safety and Efficacy for Triage of Patients with Suspected Myocardial Infarction

Roth Dominik Notfallmedizin_728

APCOV54BGM COVID-19: Auswirkungen des Tragens von persönlicher Schutzausrüstung auf die akutmedizinische Versorgung:

Eine Zwei-Szenarien-Studie

Kienbacher Calvin

Lukas Notfallmedizin_728

AP20050BGM Acute pain and immigrant status:

The impact of immigration on the treatment of pain in patients with non-traumatic pain at the emergency department

Niederdöckl Jan Notfallmedizin_728

(29)

FA728A1201 Kardiovaskuläre Forschung und Biomarker in der Notfallmedizin

"IVDR Performance Evaluation TROPT Sensitive Intermediate Precision cobas h 232 CIM RD005289"

Niederdöckl Jan Notfallmedizin_728

Fixation of the ACL using an

allograft osteosynthesis system Benca Emir Orthopädie und Unfallchirurgie_739 FA737B0201 In-vivo Testung einer

magnesiumbasierten, intramedullären Spannosteosynthese im Kaninchenmodell

Hajdu Stefan Orthopädie und Unfallchirurgie_739

AP20079BGM Einfluss der autologen Transplantatwahl und der Operationstechnik zur Rekonstruktion des vorderen Kreuzbands auf die

postoperative Muskelaktivität gemessen mittels

Tensiomyographie - eine prospektive, randomisierte Studie

Waldstein-

Wartenberg Wenzel Orthopädie und Unfallchirurgie_739

FA737A0618 Ausbildungsstipendium J&J /Funktionalität des Galektin- Netzwerks in der arthrotischen Knorpeldegeneration

Windhager Reinhard Orthopädie und Unfallchirurgie_739

FA681A0208 SFB F83: SP8 Macrophage metabolites controlling epithelial colon homeostasis

Weichhart Thomas Pathobiochemie und Genetik_306 FA681A0207 SFB F83: Coordination Project Weichhart Thomas Pathobiochemie und

Genetik_306 FA681A0403 Extracellular vesicles from

Hoffa´s fat pad- a new strategy for cartilage regeneration

Mikula Mario Pathobiochemie und Genetik_306 SP2 Metabolic crosstalk and

epigenomic repropramming of macrophages and colon cancer

Egger Gerda Pathologie_791

A Randomized, Multi-center, Double-blinded, Placebo- controlled Phase 3 Study of Nivolumab and Ipilimumab, Nivolumab Monotherapy, or Placebo in Combination with Trans-arterial

ChemoEmbolization (TACE) in Patients with Intermediate-stage Hepatocellular Carcinoma (HCC)

Kain Renate Pathologie_791

A phase II, open label,

randomized, parallel arm study of NIS793 (with and without spartalizumab) in combination with SOC chemotherapy gemcitabine/nab-paclitaxel, and gemcitabine/nab-paclitaxel alone

Herac Merima Pathologie_791

(30)

FA791A2602 A Multicenter, Double Blind, Randomized, Controlled Study of M7824 with Concurrent

Chemoradiation Followed by M7824 versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants with Unresectable Stage III Non-small Cell Lung Cancer

Geleff Silvana Pathologie_791

FA791A1909 A phase III, multicenter, randomized, double blind, placebo-controlled study evaluating the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) completely resected (R0) non- small cell lung cancer (NSCLC)

Geleff Silvana Pathologie_791

FA791A0718 Status of PIK3CA mutations from archival primary tumor and matched archival metastatic samples in HR+/HER2- breast cancer from the biobank established

Müllauer Leonhard Pathologie_791

FA791A0717 Charakterisierung von malignen Tumorerkrankungen mittels Foundation One Assay (F1 Testung)

FA791A2404 "A Phase 1/2a Dose Escalation and Cohort Expansion Study of the Safety, Tolerability, and Efficacy of Anti-LAG-3 Monoclonal Antibody (BMS- 986016) Administered Alone and in Combination with Anti-PD-1 Monoclonal Antibody

(Nivolumab, BMS-936558) in Advanced Solid Tumors. Zentrum Univ. Prof. Dr. Höller"

FA791A1018 Erhebung HER2 Statistik Kain Renate Pathologie_791 FA791A1006 Nationale Vernetzungsplattform

für personalisierte Medizin

"Plattform"

FA791A2903 A study evaluating the

PRegnancy Outcomes and Safety of Interrupting endocrine Therapy for young women with endocrine responsIVE breast cancer who desire pregnancy Zentrum Prof. Gnant

Tendl-Schulz

Kristina Pathologie_791

FA791A1127 Untersuchung von ex vivo Arzneimittelantworten in primären Proben von

hämatologischen Krebspatienten:

Eine Pilotstudie. Zentrum Prof, Jäger

Simonitsch-Klupp

Ingrid Pathologie_791

(31)

FA791A2804 A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF ATEZOLIZUMAB WITH OR WITHOUT TIRAGOLUMAB (ANTI- TIGIT ANTIBODY) IN PATIENTS WITH UN-RESECTABLE LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA”

(Skyscraper-07)

Schiefer Ana-Iris Pathologie_791

FA791A1022 Central Repository for Digital

Pathology Kain Renate Pathologie_791

FA791A1021 The purpose of the grant is to support the Banff Working Group for TMA in renal TX

FA791A0722 EPIK-B3: A Phase III, multicenter, randomized, doubleblind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nabpaclitaxel in patients with advanced triple negative breast cancer with either phosphoinositide-3-kinase catalytic subunit alpha (PIK3CA) mutation or phosphatase and tensin homolog protein (PTEN) loss without PIK3CA mutation

FA644A0405 Zukünftige stoffliche und mikrobiologische

Herausforderungen für die kommunale

Siedlungswasserwirtschaft

Sommer Regina Pathophysiologie, Infektiologie und Immunologie_370

APP34253FW Alternative viral receptors

enabling SARS-CoV-2 infection Repic Anna Pathophysiologie, Infektiologie und Immunologie_370 FA648A0306 Forschung zur Entwicklung von

aktiven und passiven Impfstoffen basierend auf der Peptid/Carrier- Technologie zur spezifischen Therapie und Prävention von viralen Erkrankungen

Valenta Rudolf Pathophysiologie, Infektiologie und Immunologie_370

APP30885FW Molecular analysis of the Guanine Nucleotide Exchange Factor Rin-like in T follicular helper cell development and function

Boucheron Nicole Pathophysiologie, Infektiologie und Immunologie_370

APP29790FW Regulation of Th Differentiation

by MAZR Ellmeier Wilfried Pathophysiologie,

Infektiologie und Immunologie_370 AP00086OFF Entwicklung von Impfstoffen und

Toleranzstrategien für Typ I Allergien

Bohle Barbara Pathophysiologie, Infektiologie und Immunologie_370 FA644A0603 EU H2020 EN_ACTI2NG Huppa Johannes Pathophysiologie, Infektiologie und

(32)

FA624A0503 Antivirale Effekte von Gluconic

Acid Stöckl Johannes Pathophysiologie,

Infektiologie und Immunologie_370 FA625A1102 Themis - Onkologische

Therapieoptionen Schabbauer Gernot Physiologie und Pharmakologie_350 Lipid Buffering Macrophages in

Adipose Tissue Schabbauer Gernot Physiologie und Pharmakologie_350 API05215FW Metal complexes with dual anti-

inflammatory activity Uhrin Pavel Physiologie und Pharmakologie_350 APP33799FW Glutamate toxicity mediated by

mitochondria Kubista Helmut Physiologie und

Pharmakologie_350 FA621A0501 Characterisation of Alzheimer's

disease Biomarkers in Blood Zellner Maria Physiologie und Pharmakologie_350 APP30026FW PTEN regulates autoimmunity by

T-cell check point inhibition

Schabbauer Gernot Physiologie und Pharmakologie_350 FA625A1102 Themis - Onkologische

Therapieoptionen Schabbauer Gernot Physiologie und Pharmakologie_350 FA621A0601 Zusammenarbeitsvereinbarung

"Apeiron Biologics AG" Schabbauer Gernot Physiologie und Pharmakologie_350 FA641A0118 Interrogating the fate of

dopamine Transporter mutants by pharmacochaperones

Freissmuth Michael Physiologie und Pharmakologie_350 APP34281FW Neuronal circuitry of experience-

induced parental care Pollak-Monje

Quiroga Daniela Physiologie und Pharmakologie_350 FA641A0117 Aktivierung von Gs-gekoppelte

EP2- Rezeptoren Zebedin-Brandl Eva

Maria Physiologie und

Pharmakologie_350 APP33955FW Engineering Diffusion Barriers in

the Plasma Membrane Sitte Harald Physiologie und Pharmakologie_350 AP20074BGM Motoric endplate reinnervation

and axonal regeneration using experimental adipose stem cell transplantation.

Supper Paul Plastische, Rekonstruktive und Ästhetische

Chirurgie_734 FA731F0801 Prävention von wiederkehrenden,

perineuralen Adhäsionen durch die Transplantation von kryokonservierter, humaner Amnionmembran

Weiss Tamara Plastische, Rekonstruktive und Ästhetische

Chirurgie_734

Immunological Parameters and Functional Magnetic Resonance Imaging in Seasonal Affective Disorder

Winkler Dietmar Psychiatrie und Psychotherapie_763

Effects of Vortioxetine in Mild Cognitive Impairment measured by Functional Magnetic

Resonance Imaging

Winkler-Pjrek Edda Psychiatrie und Psychotherapie_763

APKLI551FW Effects of TBS on 5-HT1A receptor binding in treatment resistant depression.

Kasper Siegfried Psychiatrie und Psychotherapie_763

(33)

FA763B0302 Wissenschaftlicher Support einer digitalen

Psychoedukationsplattform für unipolar depressive Patienten (edupression.com)

Pezawas Lukas Psychiatrie und Psychotherapie_763

AP19004BGM Internalized Stigma and Stigma Resistance in patients with Borderline Personality Disorder

Amering Michaela Psychiatrie und Psychotherapie_763 FA763B0302 Wissenschaftlicher Support einer

digitalen

Psychoedukationsplattform für unipolar depressive Patienten (edupression.com)

Pezawas Lukas Psychiatrie und Psychotherapie_763

FA763B0444 A Study to Evaluate the Effect of ALKS 3831 Compared to Olanzapine on Body Weight in Young Adults with

Schizophrenia,

Schizophreniform, or Bipolar Disorder Who are Early in their Illness” or “A Phase 3 Study to Assess the Long-Term Safety, Tolerability, and Durability of Treament Effect of ALKS 3831 in Subjects with Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder

Frey Richard Psychiatrie und Psychotherapie_763

FA763B0430 Clinical and biological correlates of resistant depression and related phenotypes - TRD 3

Wancata Johannes Psychiatrie und Psychotherapie_763 AP19039BGM Unerfüllter Kinderwunsch und

Lebensqualität von Paaren in IVF- Behandlung: ein Vergleich zwischen Frauen und Männern.

Quantitatives und qualitatives Pilotprojekt

Leithner-Dziubas

Katharina Psychoanalyse und Psychotherapie_766

FA766A0501 Exploring Experiences of Young Adults with the 22q11 Deletion Syndrome: A Pilot Study

Löffler-Stastka

Henriette Psychoanalyse und Psychotherapie_766 NORM2050:

Emissionsreduziertes, klimaresilientes Bauen und Wohnen in Wien im Jahr 2050

Haluza Daniela Public Health_380

AP00917OFF Mental Health Intervention für ÄrztInnen am AKH Wien

Zimmermann Claudia

Public Health_380

FA669A0106 The Physical co-morbidity costs

of mental disorders Simon Judit Public Health_380 FA636A0602 National Healthcare Systems

Changes and Challenges - Access, Inequity and Socio- Economic Inequality, a

Comparison between Kenya and Zambia

Jirovsky-Platter

Elena Public Health_380

FA636A0508 Prozessimplementierung zu Datentransfer, Datenhaltung und Datenaufbereitung im Rahmen

Sönnichsen Andreas Public Health_380